Detection of new variants in the apolipoprotein B (Apo B) gene by PCR-SSCP.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 8889592)

Published in Hum Mutat on January 01, 1996

Authors

O Poirier1, S Ricard, I Behague, C Souriau, A E Evans, D Arveiler, P Marques-Vidal, G Luc, G Roizes, F Cambien

Author Affiliations

1: INSERM SC7 Paris, France.

Articles citing this

Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet (1999) 3.02

Articles by these authors

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation (1994) 12.24

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol (1993) 10.87

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (1992) 5.56

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol (1988) 4.35

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer (1971) 3.71

Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J (2003) 3.55

Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet (1992) 3.33

The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM (1996) 3.31

Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet (1999) 3.02

Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet (1994) 2.99

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A). Cancer (1970) 2.82

The treatment of Wilms' tumor: Results of the national Wilms' tumor study. Cancer (1976) 2.80

Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77

Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ (2001) 2.74

DNA polymorphism in strains of the genus Brucella. J Bacteriol (1988) 2.70

Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet (1971) 2.65

Effect of multidimensional lifestyle intervention on fitness and adiposity in predominantly migrant preschool children (Ballabeina): cluster randomised controlled trial. BMJ (2011) 2.60

Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation (1999) 2.56

Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension (1996) 2.44

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum Mol Genet (1999) 2.41

Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension (1994) 2.41

Mobile coronary care and community mortality from myocardial infarction. Lancet (1985) 2.27

Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment. Cancer Invest (1983) 2.16

Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet (1993) 2.06

Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol (1980) 2.06

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. BMJ (1996) 1.99

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia (1989) 1.96

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol (1989) 1.92

Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr (2010) 1.92

Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes (1994) 1.85

Incidence of childhood cancer: experience of a decade in a population-based registry. J Natl Cancer Inst (1983) 1.85

Pulsed-field gel electrophoresis determination of the genome size of obligate intracellular bacteria belonging to the genera Chlamydia, Rickettsiella, and Porochlamydia. J Bacteriol (1989) 1.79

Blood cholesterol: is population screening warranted in the UK? Lancet (1989) 1.76

Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension (1989) 1.72

Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology (2007) 1.64

The Mediterranean diet revisited--towards resolving the (French) paradox. QJM (2000) 1.61

Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas (2009) 1.61

Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia (1995) 1.57

Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology (2011) 1.57

Leisure-time physical activity and regular walking or cycling to work are associated with adiposity and 5 y weight gain in middle-aged men: the PRIME Study. Int J Obes Relat Metab Disord (2001) 1.53

Reliability of reported family history of myocardial infarction. BMJ (1993) 1.52

Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation (2004) 1.52

Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2005) 1.52

Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest (2001) 1.51

A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med (1977) 1.51

New polymorphisms in the interleukin-10 gene--relationships to myocardial infarction. Eur J Clin Invest (2001) 1.50

Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet (1996) 1.50

Sex differences in awareness and control of hypertension in France. J Hypertens (1997) 1.49

Prognostic factor in neuroblastoma. Cancer (1987) 1.47

Pre-hospital coronary care and coronary fatality in the Belfast and Glasgow MONICA populations. Int J Epidemiol (2005) 1.47

Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest (1995) 1.46

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb (1992) 1.45

Treatment and prognostic factors in patients with hepatocellular carcinoma. Liver Int (2006) 1.43

Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene. Circulation (1996) 1.43

New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol (2000) 1.42

Colonoscopies in Portuguese district hospitals: a multicentric transverse study. Dig Liver Dis (2006) 1.42

Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136-->Ser) Br J Nutr (2000) 1.40

Distribution of lipid variables in subjects in Belfast, Northern Ireland and Taiyuan, P R China. Atherosclerosis (1993) 1.39

Infrainguinal bypass for peripheral arterial occlusive disease: when arms save legs. Eur J Vasc Endovasc Surg (2011) 1.37

Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study. Diabet Med (2012) 1.36

Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med (1994) 1.36

Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation (1998) 1.35

The epidemiology of disease expenses. The costs of caring for children with cancer. JAMA (1985) 1.35

Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol (2000) 1.34

Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci U S A (2000) 1.33

Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J (1995) 1.31

MethDB--a public database for DNA methylation data. Nucleic Acids Res (2001) 1.30

Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol (1999) 1.30

Successful overweight prevention in adolescents by increasing physical activity: a 4-year randomized controlled intervention. Int J Obes (Lond) (2008) 1.29